Cargando…

Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events

BACKGROUND: Incorporating patient reporting of symptomatic adverse events (AEs) is important in evaluating safety and tolerability in cancer clinical trials. The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to assess the frequency,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speck, Rebecca M., Lenderking, William R., Shaw, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104407/ https://www.ncbi.nlm.nih.gov/pubmed/30175317 http://dx.doi.org/10.1186/s41687-018-0063-4

Ejemplares similares

Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations
por: Zhu, Yanyan, et al.
Publicado: (2022)

Disclosure of Adverse Events: A Guide for Clinicians
por: Peterson, Kimberly A., et al.
Publicado: (2019)

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events
por: Atkinson, Thomas M., et al.
Publicado: (2018)

Voice of the Clinician: the case of an Australian health system
por: Lock, Mark J., et al.
Publicado: (2017)

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022)

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients
por: Barilà, Gregorio, et al.
Publicado: (2023)

Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study
por: Hohl, Corinne M, et al.
Publicado: (2018)

Understanding clinician perspectives on antibiotic associated adverse events to inform feedback
por: Cherian, Jerald, et al.
Publicado: (2023)

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
por: Müller, Benjamin, et al.
Publicado: (2023)

Patient voice on management of facial dermatological adverse events with targeted therapies: a qualitative study
por: Yagasaki, Kaori, et al.
Publicado: (2019)

“Attitudes to voices”: a survey exploring the factors influencing clinicians’ intention to assess distressing voices and attitudes towards working with young people who hear voices
por: Rammou, Aikaterini, et al.
Publicado: (2023)

Integrative analysis identifies three molecular subsets in ovarian cancer
por: Liu, Bo, et al.
Publicado: (2022)

A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events
por: Janse van Rensburg, Helena J., et al.
Publicado: (2023)

Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis
por: Abbas, Azhar, et al.
Publicado: (2014)

Debate: A subversive view of subsets - a dissident clinician's opinion
por: Julian, Desmond G
Publicado: (2000)

Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
por: Signoriello, Elisabetta, et al.
Publicado: (2023)

Barriers to disseminating brief CBT for voices from a lived experience and clinician perspective
por: Hazell, Cassie M., et al.
Publicado: (2017)

Exploring differences in symptomatic adverse events assessment between nurses and physicians in the clinical trial setting
por: Liu, Lei, et al.
Publicado: (2023)

Integrating voice and data networks
por: Keagy, Scott
Publicado: (2000)

From voice to voices: identifying a plurality of Muslim sources in the news media
por: Munnik, Michael B
Publicado: (2017)

Identifying Voice Individuality Unaffected by Age-Related Voice Changes during Adolescence
por: Suzuki, Natsumi, et al.
Publicado: (2022)

Specific adverse events predict survival rates in a Chinese population diagnosed with hepatocellular carcinoma and treated with sorafenib
por: Lee, Shou‐Wu, et al.
Publicado: (2018)

Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI
por: Boidin, Maxime, et al.
Publicado: (2023)

Perspectives on the use of aromatherapy from clinicians attending an integrative medicine continuing education event
por: Pearson, Amy C. S., et al.
Publicado: (2019)

Patients’ experience of communication and handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy
por: Bæksted, Christina Witt, et al.
Publicado: (2019)

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
por: Soria, Anna, et al.
Publicado: (2022)

Adverse event detection by integrating twitter data and VAERS
por: Wang, Junxiang, et al.
Publicado: (2018)

Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey
por: Hall, Lewis, et al.
Publicado: (2023)

Using prospective clinical surveillance to identify adverse events in hospital
por: Forster, Alan J, et al.
Publicado: (2011)

A Personalized and Learning Approach for Identifying Drugs with Adverse Events
por: Shin, Sug Kyun, et al.
Publicado: (2017)

Are All Vaccines Created Equal? Using Electronic Health Records to Discover Vaccines Associated With Clinician-Coded Adverse Events
por: Boland, Mary Regina, et al.
Publicado: (2015)

Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma
por: Lim, Huat Chye, et al.
Publicado: (2021)

Adverse events and nocebo phenomena: treatment or disease specific?
por: Zis, Panagiotis, et al.
Publicado: (2019)

Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data
por: Weingart, Saul N., et al.
Publicado: (2020)

Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer
por: Wang, Huina, et al.
Publicado: (2023)

A Unique Subset of Self-specific Intraintestinal T Cells Maintains Gut Integrity
por: Poussier, Philippe, et al.
Publicado: (2002)

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events
por: Kawaguchi, Takashi, et al.
Publicado: (2018)

Do adverse life events at first onset of auditory verbal hallucinations influence subsequent voice characteristics? Results from an epidemiological study()
por: Bless, Josef J., et al.
Publicado: (2018)

Tolerance and adverse event profile with sorafenib in Indian patients with advanced hepatocellular carcinoma
por: Ostwal, Vikas, et al.
Publicado: (2017)

Sorafenib-Related Adverse Events in Predicting the Early Radiologic Responses of Hepatocellular Carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b5dlbr039qfo9rjd278726gg7j